Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.79 +0.49 / +1.43%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.79 -0.0042 / -0.01%
Volume: 12.6K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line100.7M112.2M147.1M176.2M
Total Other Cash Flow-15.7M15.8M51.4M52.0M
Funds From Operations145.4M170.6M214.9M250.2M
Funds From/For Other Operating Expenses14.6M28.8M41.0M60.0M
Net Cash Flow - Operating Activities130.8M141.8M173.9M190.2M
InvestingIncrease In Investments-425.2M-388.1M-448.8M-385.3M
Decrease In Investments456.1M385.2M384.6M381.9M
Capital Expenditures-3.8M-9.4M-11.4M-14.3M
Net Assets From Acquisitions -79.4M-799.0K0.000.00
Other Investing - Uses0.00-25.1M0.000.00
Net Cash Flow Investing-54.4M-38.9M-75.6M-17.7M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale25.1M25.0M57.8M64.8M
Common Preferred Redeemed-200.5M-128.5M-146.3M-287.7M
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing58.8M34.2M7.9M11.1M
Other Uses - Financing0.
Net Cash Flow - Financing-116.6M-69.2M-80.6M-211.8M
Exchange RateEffect of Exchange Rate on Cash71.0K-42.0K0.000.00
Net Change In Cash-40.2M33.7M17.7M-39.3M

To view my watchlist

Not a member yet?

Sign up now for a free account